Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also ...
Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.
Risk of recurrent major adverse limb events was lower in diabetes patients taking GLP-1 agents compared with DPP-4 inhibitors ...
Lawsuits continue against makers of GLP-1 weight-loss drugs over side effects ranging from extreme vomiting to what some ...
By Deanna Neff HealthDay ReporterTHURSDAY, Jan. 29, 2026 (HealthDay News) — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price ...
Optimizing bispecific AE management in the community requires a combination of standardized clinical protocols, reliable educational tools, and robust communication networks with academic partners.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results